Patents by Inventor Robert L. Warning
Robert L. Warning has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20140312023Abstract: A welding gun neck for a welding gun includes an elongated tubular body having an end connectable to a gas diffuser. The elongated tubular body includes a threaded external surface adjacent the end. The threaded external surface defines a male, threaded portion. The male, threaded portion is mateable with a female thread of the gas diffuser. The threaded external surface includes a straight portion and an adjoining tapered portion. The welding gun neck is connectable to both a gas diffuser having a straight female thread and a gas diffuser having a tapered female thread.Type: ApplicationFiled: April 23, 2013Publication date: October 23, 2014Applicant: ILLINOIS TOOL WORKS INC.Inventors: Robert J. Centner, Duane S. Snapp, Robert L. Warning
-
Patent number: 7932262Abstract: The invention provides quinazoline compounds that are inhibitors of PDK1. Also provided are pharmaceutical compositions including the compounds, and methods of treating proliferative diseases, such as cancers, with the compounds or compositions.Type: GrantFiled: April 5, 2007Date of Patent: April 26, 2011Assignee: Novartis AGInventors: Savithri Ramurthy, Xiaodong Lin, Sharadha Subramanian, Alice Rico, Xiaojong M. Wang, Rama Jain, Jeremy M. Murray, Stephen E. Basham, Robert L. Warne, Wei Shu, Yasheen Zhou, Jeffrey Dove, Mina Aikawa, Payman Amiri, Weibo Wang, Johanna M. Jansen, Allan S. Wagman, Keith B. Pfister, Simon Ng
-
Publication number: 20100216767Abstract: The invention provides novel compounds that are inhibitors of PDK1. Also provided are pharmaceutical compositions including the compounds, and methods of treating proliferative diseases, such as cancers, with the compounds or compositions.Type: ApplicationFiled: December 20, 2007Publication date: August 26, 2010Inventors: Mina Aikawa, Payman Amiri, Steven Bashman, Jeffrey Dove, Rama Jain, Xiaodong Lin, Jeremy Murray, Savithri Ramurthy, Alice Rico, Wei Shu, Sharadha Subramanian, Xiaojing Michael Wang, Robert L. Warne, Yasheen Zhou
-
Publication number: 20100048561Abstract: The invention provides quinazoline compounds that are inhibitors of PDK1. Also provided are pharmaceutical compositions including the compounds, and methods of treating proliferative diseases, such as cancers, with the compounds or compositions.Type: ApplicationFiled: April 5, 2007Publication date: February 25, 2010Applicant: NOVARTIS VACCINES & DIAGNOSTICS, INC.Inventors: Savithri Ramurthy, Xiaodong Lin, Sharadha Subramanian, Alice C. Rico, Xiaojing M. Wang, Rama Jain, Jeremy M. Murray, Steven E. Basham, Robert L. Warne, Wei Shu, Yasheen Zhou, Jeffrey Dove, Mina Aikawa, Payman Amiri, Weibo Wang, Johanna M. Jansen, Allan S. Wagman, Keith B. Pfister, Simon Ng
-
Patent number: 7439040Abstract: A polypeptide containing an anchor region, a protease recognition site, and a detectable signal region can be produced recombinantly and directly attached to a solid support. The polypeptide is useful for screening protease regulators, especially protease inhibitors.Type: GrantFiled: August 1, 2005Date of Patent: October 21, 2008Assignee: Novartis Vaccines and Diagnostics, Inc.Inventors: David Y. Chien, Mark J. Selby, Kevin Shoemaker, Robert L. Warne
-
Patent number: 6924122Abstract: A polypeptide containing an anchor region, a protease recognition site, and a detectable signal region can be produced recombinantly and directly attached to a solid support. The polypeptide is useful for screening protease regulators, especially protease inhibitors.Type: GrantFiled: August 20, 2002Date of Patent: August 2, 2005Assignee: Chiron CorporationInventors: David Y. Chien, Mark J. Selby, Kevin Shoemaker, Robert L. Warne
-
Publication number: 20030113825Abstract: A polypeptide containing an anchor region, a protease recognition site, and a detectable signal region can be produced recombinantly and directly attached to a solid support. The polypeptide is useful for screening protease regulators, especially protease inhibitors.Type: ApplicationFiled: August 20, 2002Publication date: June 19, 2003Inventors: David Y. Chien, Mark J. Selby, Kevin Shoemaker, Robert L. Warne
-
Patent number: 6436666Abstract: A polypeptide containing an anchor region, a protease recognition site, and a detectable signal region can be produced recombinantly and directly attached to a solid support. The polypeptide is useful for screening protease regulators, especially protease inhibitors.Type: GrantFiled: October 17, 1997Date of Patent: August 20, 2002Assignee: Chiron CorporationInventors: David Y. Chien, Mark J. Selby, Kevin Shoemaker, Robert L. Warne
-
Patent number: 5605932Abstract: Compounds of Formula 1 bind opioid receptors: which binds to the opioid receptor: ##STR1##Type: GrantFiled: January 2, 1996Date of Patent: February 25, 1997Assignee: Chiron CorporationInventors: Simon Ng, Robert L. Warne, Ronald N. Zuckermann, Eric J. Martin, Reyna J. Simon
-
Patent number: 5567602Abstract: The instant invention is directed to recombinant production of functionally active chymase. "Functionally active" as used herein refers to the ability to exhibit one or more functional activities of a full-length wild-type chymase protein. In a preferred aspect, a proteolytically inactive chymase fusion protein comprising a functionally active portion of a non-chymase protein joined to the amino-terminus of the chymase protein is produced, which, upon cleavage away of the non-chymase fusion protein portion, becomes proteolytically active. A refolding procedure for increasing yields of proteolytically active recombinant chymase is provided. The invention is further directed to use of the recombinant chymase thus produced for preparing chymase-specific antibodies.Type: GrantFiled: August 12, 1992Date of Patent: October 22, 1996Assignee: Arris Pharmaceutical CorporationInventors: James M. Clark, Kevin R. Shoemaker, Robert L. Warne
-
Patent number: 5536868Abstract: Compounds of Formula 1 bind to the opioid receptors: ##STR1## wherein R.sub.1 is a group of the formula ##STR2## where W is --(CH.sub.2).sub.a -- (where a is 0, 1, or 2), --O--, --NH--, --S--, --SO--, or --SO.sub.2 --, and Ar is phenyl, phenyl-alkyl, phenyl substituted with 1-3 halo, nitro, lower alkyl, hydroxy, amino, alkylamino, dialkylamino, and/or hydroxy-lower alkyl groups, and n is 0, 1, 2, 3, or 4;R.sub.2 and R.sub.3 are each independently H, lower alkyl, or ##STR3## where X is H, OH, lower alkyl, or lower alkoxy, and p is 0, 1, 2, or 3; R.sub.4 is ##STR4## where m is 0, 1, 2, or 3, and R is 1-3 halo, nitro, lower alkyl, hydroxy, amino, alkylamino, dialkylamino, and/or hydroxy-lower alkyl groups;R.sub.5 is cycloalkyl, bicycloalkyl, or tricycloalkyl; andR.sub.6, R.sub.7, R.sub.8, and R.sub.9 are each independently H or lower alkyl.Type: GrantFiled: February 21, 1995Date of Patent: July 16, 1996Assignee: Chiron CorporationInventors: Simon Ng, Robert L. Warne, Ronald N. Zuckermann, Eric J. Martin, Reyna J. Simon
-
Patent number: 5481020Abstract: Compounds of Formula 1 bind opioid receptors: which binds to the opioid receptor: ##STR1##Type: GrantFiled: December 30, 1994Date of Patent: January 2, 1996Assignee: Chiron CorporationInventors: Simon Ng, Robert L. Warne, Ronald N. Zuckermann, Eric J. Martin, Reyna J. Simon
-
Patent number: D449369Type: GrantFiled: August 31, 2000Date of Patent: October 16, 2001Assignee: Illinois Tool Works Inc.Inventors: Daniel J. Hanzel, Harshad Shah, Robert L. Warning